Search results
Despite currently being unprofitable, Relief Therapeutics Holding (VTX:RLF) has delivered a 644%...
Simply Wall St. via Yahoo Finance· 1 year agoRelief Therapeutics Holding AG (VTX:RLF) shareholders have seen the share price descend 16% over the...
Relief Therapeutics Holding First Half 2023 Earnings: CHF5.10 loss per share (vs CHF2.55 loss in 1H...
Simply Wall St. via Yahoo Finance· 9 months agoRelief Therapeutics Holding (VTX:RLF) First Half 2023 Results Key Financial Results Net loss:...
Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate
Benzinga via Yahoo Finance· 2 years agoRelief Therapeutics Holding SA (OTC: RLFTF) (OTC: RLFTD) and NRx Pharmaceuticals Inc (NASDAQ: NRXP)...
FDA Rejects Acer Therapeutics - Relief Therapeutics' Urea Cycle Disorder Candidate
Benzinga via Yahoo Finance· 2 years agoThe FDA issued a Complete Response Letter regarding the marketing application for Acer Therapeutics...
Acer (ACER) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on updates of Acer Therapeutics’ ACER pipeline and revenue guidance for...
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with many important pipeline and regulatory updates. Collaboration...
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 1 week agoIn 2023, the Swiss Biotech Association reported that the life sciences sector—pharmaceuticals,...
Biotech Stock Roundup: MRNA's Jab Update, ACER Down on Regulatory News & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
ACER Down Despite FDA Nod for Urea Cycle Disorders Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves Acer Therapeutics' (ACER) Olpruva (sodium phenylbutyrate) to treat certain patients...